These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31905399)

  • 1. Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics.
    Whittles LK; White PJ; Didelot X
    Clin Infect Dis; 2020 Nov; 71(8):1912-1919. PubMed ID: 31905399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis.
    Whittles LK; Didelot X; White PJ
    Lancet Infect Dis; 2022 Jul; 22(7):1030-1041. PubMed ID: 35427491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection Among Urban Men Who Have Sex With Men.
    Hui BB; Padeniya TN; Rebuli N; Gray RT; Wood JG; Donovan B; Duan Q; Guy R; Hocking JS; Lahra MM; Lewis DA; Whiley DM; Regan DG; Seib KL
    J Infect Dis; 2022 Mar; 225(6):983-993. PubMed ID: 34894134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Planning for a Gonococcal Vaccine: A Narrative Review of Vaccine Development and Public Health Implications.
    Abara WE; Jerse AE; Hariri S; Kirkcaldy RD
    Sex Transm Dis; 2021 Jul; 48(7):453-457. PubMed ID: 33201019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.
    Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O
    Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol.
    Thng C; Semchenko EA; Hughes I; O'Sullivan M; Seib KL
    BMC Public Health; 2023 Mar; 23(1):607. PubMed ID: 36997957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating spatially adaptive guidelines for the treatment of gonorrhea to reduce the incidence of gonococcal infection and increase the effective lifespan of antibiotics.
    Yaesoubi R; Cohen T; Hsu K; Gift TL; St Cyr SB; Salomon JA; Grad YH
    PLoS Comput Biol; 2022 Feb; 18(2):e1009842. PubMed ID: 35139073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonococcal Vaccines for Controlling Neisseria gonorrhoeae in Men Who Have Sex With Men: A Promising Game Changer.
    Christensen H; Vickerman P
    J Infect Dis; 2022 Mar; 225(6):931-933. PubMed ID: 34894131
    [No Abstract]   [Full Text] [Related]  

  • 10. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the population level impact of a gonococcal vaccine candidate: Predictions from a simple mathematical model.
    Carey KA; Newman LM; Spicknall IH
    Vaccine; 2022 Nov; 40(50):7176-7181. PubMed ID: 36333224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential impact of vaccination on the prevalence of gonorrhea.
    Craig AP; Gray RT; Edwards JL; Apicella MA; Jennings MP; Wilson DP; Seib KL
    Vaccine; 2015 Aug; 33(36):4520-4525. PubMed ID: 26192351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcus B Vaccination Effectiveness Against Neisseria gonorrhoeae Infection in People Living With HIV: A Case-Control Study.
    Raccagni AR; Galli L; Spagnuolo V; Bruzzesi E; Muccini C; Bossolasco S; Ranzenigo M; Gianotti N; Lolatto R; Castagna A; Nozza S
    Sex Transm Dis; 2023 May; 50(5):247-251. PubMed ID: 36728240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.
    Semchenko EA; Tan A; Borrow R; Seib KL
    Clin Infect Dis; 2019 Sep; 69(7):1101-1111. PubMed ID: 30551148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Susceptibility of Urogenital and Extragenital Neisseria gonorrhoeae Isolates Among Men Who Have Sex With Men: Strengthening the US Response to Resistant Gonorrhea and Enhanced Gonococcal Isolate Surveillance Project, 2018 to 2019.
    Quilter LAS; St Cyr SB; Hong J; Asbel L; Bautista I; Carter B; Casimir Y; Denny M; Ervin M; Gomez R; Harvey A; Holderman JL; Johnson K; Kohn RP; Learner ER; Mauk K; Menza T; Mettenbrink C; Nettleton WD; Nicosia KR; Pham CD; Ried C; Schlanger K; Schneider A; Soge OO; Tabidze I; Taylor SN; Tilghman W; Toler C; Weinstock H; Torrone EA
    Sex Transm Dis; 2021 Dec; 48(12S Suppl 2):S111-S117. PubMed ID: 34475363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance-minimising strategies for introducing a novel antibiotic for gonorrhoea treatment: a mathematical modelling study.
    Reichert E; Yaesoubi R; Rönn MM; Gift TL; Salomon JA; Grad YH
    Lancet Microbe; 2023 Oct; 4(10):e781-e789. PubMed ID: 37619582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential public health impact of adolescent 4CMenB vaccination on Neisseria gonorrhoeae infection in England: a modelling study.
    Looker KJ; Booton R; Begum N; Beck E; Shen J; Turner KME; Christensen H
    BMC Public Health; 2023 Jan; 23(1):1. PubMed ID: 36624437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
    Kirkcaldy RD; Zaidi A; Hook EW; Holmes KK; Soge O; del Rio C; Hall G; Papp J; Bolan G; Weinstock HS
    Ann Intern Med; 2013 Mar; 158(5 Pt 1):321-8. PubMed ID: 23460055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
    Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
    PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.